Roivant Sciences (STU:87S) FCF Yield % : -10.08 (As of Mar. 23, 2025)

View and export this data going back to 2023. Start your Free Trial

What is Roivant Sciences FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Roivant Sciences's Trailing 12-Month Free Cash Flow is €-721.1 Mil, and Market Cap is €7,092.0 Mil. Therefore, Roivant Sciences's FCF Yield % for today is -10.08%.

The historical rank and industry rank for Roivant Sciences's FCF Yield % or its related term are showing as below:

STU:87S' s FCF Yield % Range Over the Past 10 Years
Min: -39.07 Med: -11.21 Max: -7.39
Current: -10.08

During the past 4 years, the highest FCF Yield % of Roivant Sciences was -7.39%. The lowest was -39.07%. And the median was -11.21%.

STU:87S's FCF Yield % is ranked better than
56.13% of 1502 companies
in the Biotechnology industry
Industry Median: -14.29 vs STU:87S: -10.08

Roivant Sciences's FCF Margin % for the quarter that ended in Dec. 2024 was -2,318.51%.

Roivant Sciences FCF Yield % Historical Data

The historical data trend for Roivant Sciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roivant Sciences FCF Yield % Chart

Roivant Sciences Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

FCF Yield %

-15.65

-9.06

Roivant Sciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial														-9.42	-5.14	-9.91	-12.78	-9.96

Competitive Comparison of Roivant Sciences's FCF Yield %

For the Biotechnology subindustry, Roivant Sciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roivant Sciences's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Roivant Sciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Roivant Sciences's FCF Yield % falls into.

Roivant Sciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Roivant Sciences's FCF Yield % for the fiscal year that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-705.318	/	7784.4427
	=	-9.06%

Roivant Sciences's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-199.67	*	4	/	8020.29864
	=	-9.96%

Roivant Sciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Roivant Sciences FCF Yield % Related Terms

Thank you for viewing the detailed overview of Roivant Sciences's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Roivant Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roivant Sciences Ltd (STU:87S) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

ROIV:USA 87S:Germany

Address

50 Broadway, 7th Floor, London, GBR, SW1H 0BD

Website

https://www.roivant.com

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Roivant Sciences Headlines

No Headlines